Form 4 for IDXX Idexx Laboratories
Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-13 · accession 0001567619-21-016001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-08-17 | 2021-08-13+ | IDXX | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | S - Sale | $675.21 | -6,000 | 49.5K | -11% | -$4.05M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-13 | S | D | 3,417 | $675.34 | 52,009.64 | D | — | — | (F1) Represents the weighted average price of the shares sold ranging from a low of $675.00 to a high of $675.89 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2021-08-13 | S | D | 337 | $677.58 | 50,689.64 | D | — | — | (F3) Represents the weighted average price of the shares sold ranging from a low of $677.13 to a high of $677.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 3 | Common | Common Stock | 2021-08-16 | S | D | 60 | $675.44 | 49,426.64 | D | — | — | (F7) Represents the weighted average price of the shares sold ranging from a low of $675.29 to a high of $675.47 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 4 | Common | Common Stock | 2021-08-13 | S | D | 983 | $676.38 | 51,026.64 | D | — | — | (F2) Represents the weighted average price of the shares sold ranging from a low of $676.01 to a high of $676.99 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 5 | Common | Common Stock | 2021-08-16 | S | D | 533 | $672.36 | 50,156.64 | D | — | — | (F4) Represents the weighted average price of the shares sold ranging from a low of $672.08 to a high of $673.02 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 6 | Common | Common Stock | 2021-08-16 | S | D | 488 | $673.69 | 49,668.64 | D | — | — | (F5) Represents the weighted average price of the shares sold ranging from a low of $673.13 to a high of $674.07 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 7 | Common | Common Stock | 2021-08-16 | S | D | 182 | $674.48 | 49,486.64 | D | — | — | (F6) Represents the weighted average price of the shares sold ranging from a low of $674.16 to a high of $674.91 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |